Etain · European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2011 · narrative review · n=?

Genetics of circadian rhythms and mood spectrum disorders.

Cited 160 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review synthesizing genetic association literature without systematic review methodology.

PubMed 21835597 · doi:10.1016/j.euroneuro.2011.07.007 · record verified 2026-08-30

What was done

This narrative review summarizes evidence regarding circadian rhythm alterations—such as actigraphic abnormalities, shifted social rhythms, diurnal preferences, and altered melatonin secretion—and genetic association studies evaluating clock gene variants (including CLOCK, ARNTL1, NPAS2, PER3, and NR1D1) across mood spectrum disorders (bipolar disorder, recurrent depressive disorder, and seasonal affective disorder).

What was found

The abstract provides no quantitative data, effect sizes, or statistical figures. It qualitatively reports that circadian disruptions occur during both acute mood episodes and euthymic states (especially in remitted bipolar disorder), and that genetic variants in CLOCK, ARNTL1, NPAS2, PER3, and NR1D1 have been repeatedly associated with bipolar disorder, and to a lesser degree with recurrent depression and seasonal affective disorder.

Why it matters

Identifying circadian gene variants and rhythm dysfunctions helps frame circadian disruptions not merely as symptoms, but as potential heritable biological markers and pathophysiological drivers of mood spectrum disorders.

Limits

The abstract contains no quantitative metrics, sample sizes, or search parameters. As a narrative review, it lacks systematic search methodology, assessment of study quality, or meta-analytic control for publication bias and confounding across primary genetic association studies.

Cited by